This is a very aggressive type of brain tumor. It's called a glioblastoma with sarcomatous component. It's a rare and fast-growing tumor that can occur in the brain or spinal cord. It contains both cancerous (malignant) brain cells (glial cells) and cancer cells from other tissues (sarcomatous). These tumors can grow very quickly and often cause symptoms like headaches or seizures. They can sometimes happen after radiation therapy to the brain.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Gliosarcoma?
Gliosarcoma is a rare, fast-growing cancer that starts in the brain or, less often, the spinal cord. Under a microscope it has two kinds of tumor cells mixed together: cells that resemble glial cells (the brain's supporting cells) and cells that resemble sarcoma, a cancer of connective tissue. That mixed appearance gives the tumor its name. Doctors now classify gliosarcoma as a variant of glioblastoma, the most common aggressive brain cancer in adults, and about 2 percent of glioblastomas are gliosarcomas. Like glioblastoma, it is a grade 4 tumor, the highest grade, meaning it grows quickly and invades nearby brain tissue. Symptoms depend on where the tumor sits and can include headaches, seizures, weakness or numbness, trouble with balance, and changes in memory or thinking. Gliosarcoma can spread through the fluid around the brain and spinal cord, but it generally does not spread to other organs.
The cause of most gliosarcomas is not known. Like other cancers, it grows from changes in the genes that control how cells divide, but in most people these changes arise for no identifiable reason and are not inherited or caused by anything the person did. Gliosarcoma can occur at any age but is most often diagnosed between 40 and 60. Doctors distinguish two forms. Primary gliosarcoma is found at the first surgery or biopsy. Secondary gliosarcoma develops from an existing glioma (a tumor of glial cells), usually after that tumor was treated with radiation. Previous radiation to the head and a few rare inherited genetic conditions are linked to a higher chance of glioblastoma-type tumors, but most people with those exposures never develop one.
Evaluation usually begins after symptoms such as seizures, new headaches or weakness lead to a brain scan. MRI (magnetic resonance imaging) with contrast dye is the main imaging test. Gliosarcoma often appears as a single mass near the surface of the brain, sometimes attached to its outer covering, that lights up with contrast and is surrounded by swelling. Imaging can suggest a high-grade tumor, but it cannot tell gliosarcoma apart from glioblastoma, a meningioma (a usually slow-growing tumor of the brain's covering) or other masses. A firm diagnosis requires tumor tissue, removed during surgery or by a needle biopsy, examined by a neuropathologist (a specialist in brain tumor tissue). The lab also tests the tumor's genetic features. One of these, MGMT methylation, describes whether a DNA repair gene called MGMT is switched off in the tumor; in studies of gliosarcoma and glioblastoma it is linked to longer survival.
There is currently no cure for gliosarcoma, but treatment can slow the tumor, relieve symptoms and extend life. Care follows the same approach used for glioblastoma and is usually planned by a team including a neurosurgeon, a radiation oncologist and a neuro-oncologist. The first step is usually surgery to remove as much tumor as can be taken out without causing new problems with movement, speech or thinking. In studies of gliosarcoma, removing all visible tumor was associated with longer survival, though that is not always safely possible. Surgery is typically followed by several weeks of radiation therapy given together with temozolomide (Temodar), an oral chemotherapy, and then several more months of temozolomide alone. Studies of gliosarcoma link both radiation and temozolomide-based chemotherapy with longer survival, although this evidence comes from observational studies rather than trials designed for this tumor. Supportive treatment matters too. Antiseizure medicines control seizures, and steroid medicines can reduce brain swelling and the symptoms it causes. When the tumor returns, there is no single standard approach: options can include another surgery, more radiation, other chemotherapy, or bevacizumab (Avastin), an antibody that blocks a tumor's ability to grow new blood vessels. Clinical trials testing new drugs and immunotherapies are open to many people with gliosarcoma and are worth asking about at diagnosis, not only after other options are exhausted.
Gliosarcoma is a serious diagnosis, and it usually comes back even after full treatment. Published case series report a median survival of roughly 13 to 16 months, meaning about half of people live shorter and half live longer. Reliable statistics are limited because the tumor is rare. Outlook tends to be better for younger people, those whose tumor could be fully removed and those whose tumor has MGMT methylation. Secondary gliosarcoma, which follows earlier treatment for another glioma, generally has a poorer outlook than primary gliosarcoma. Daily life depends on where the tumor is and how treatment affects the person. Some people have weakness, word-finding problems or memory changes that shape what they can do independently, and these may change over time. Regular follow-up MRI scans track whether the tumor is stable or growing and guide decisions about further treatment. Brain tumor centers can also help people cope with the physical and emotional effects of the diagnosis, and planning ahead for care and personal wishes is worth starting early, while the person can take a full part in those decisions.
See a doctor about a new headache that is worse in the morning or with vomiting, or gradual changes in vision, speech, balance, strength, personality or thinking. These symptoms have many causes, but a brain tumor is one that needs to be ruled out. For someone already being treated, contact the care team promptly about new or worsening weakness, confusion, headaches or seizures, since these can signal brain swelling, tumor growth or a treatment side effect that needs adjustment. Call 911 for a first seizure, a seizure that lasts longer than 5 minutes, seizures that repeat without the person waking up in between, or if the person becomes very hard to wake.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Gliosarcoma is like, what's helped you, or ask the community a question.